Colinz Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

2.52

3.55

3.55

3.54

3.54

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

5.62

4.14

3.75

3.29

3.30

Loan funds

Secured loans

0.27

0.48

0.99

0.38

0.68

Unsecured loans

-

-

-

-

-

Total

8.41

8.17

8.28

7.22

7.52

Uses of funds

Fixed assets

Gross block

6.17

6.91

6.88

6.72

6.67

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

4.46

5.05

4.85

4.66

4.46

Net block

1.71

1.86

2.03

2.06

2.21

Capital work-in-progress

-

-

-

-

-

Investments

0.66

0.67

0.61

0.36

0.50

Net current assets

Current assets, loans & advances

7.86

7.40

7.46

6.39

6.47

Less : current liabilities & provisions

1.82

1.76

1.81

1.59

1.66

Total net current assets

6.04

5.64

5.65

4.80

4.81

Miscellaneous expenses not written

-

-

-

-

-

Total

8.41

8.17

8.28

7.22

7.52

Notes:

Book value of unquoted investments

0.66

0.67

0.61

0.36

0.01

Market value of quoted investments

-

-

-

-

0.47

Contingent liabilities

0.28

24,367.23

0.25

0.22

0.18

Number of equity sharesoutstanding (Lacs)

25.19

35.45

35.45

35.44

35.44